Radiolabeled mAbs as Molecular Imaging and/or Therapy Agents Targeting PSMA

被引：12

作者：

Psimadas, Dimitrios ^{[1
]}

Valotassiou, Varvara ^{[1
]}

Alexiou, Sotiria ^{[1
]}

Tsougos, Ioannis ^{[1
]}

Georgoulias, Panagiotis ^{[1
]}

机构：

[1] Univ Thessaly, Sch Med, Univ Hosp Larissa, Dept Nucl Med, Larisa, Greece

来源：

CANCER INVESTIGATION | 2018年 / 36卷 / 02期

关键词：

Antibodies; radiolabeling; PSMA; prostate cancer; LU-177-PSMA-617 RADIOLIGAND THERAPY; METASTATIC PROSTATE-CANCER; MEMBRANE ANTIGEN PSMA; MONOCLONAL-ANTIBODY J591; IN-VIVO; PRECLINICAL EVALUATION; EXTRACELLULAR DOMAIN; RADIATION-DOSIMETRY; INHIBITORS; TUMORS;

D O I：

10.1080/07357907.2018.1430816

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Molecular imaging and therapy is a rapidly evolving field in research and clinical medicine. The use of the exciting and attractive properties of radioisotopes for imaging and therapy has made Nuclear Medicine very significant when it comes to molecular imaging/therapy. Monoclonal Antibodies (mAbs) on the other hand are very important targeting biomolecules with high affinity that can "carry" the radioisotope of choice. Herein we make a brief overview of the radiolabeled mAbs that target prostate specific membrane antigen (PSMA) and their use in the management of patients with prostate cancer (PCa).

引用

页码：118 / 128

页数：11

共 50 条

[21] PSMA-Targeting Imaging and Theranostic Agents-Current Status and Future Perspective
Debnath, Sashi
Zhou, Ning
McLaughlin, Mark
Rice, Samuel
Pillai, Anil K.
Hao, Guiyang
Sun, Xiankai
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (03)
[22] Targeting of microbubbles: contrast agents for ultrasound molecular imaging
Wang, Shiying
Hossack, John A.
Klibanov, Alexander L.
JOURNAL OF DRUG TARGETING, 2018, 26 (5-6) : 420 - 434
[23] Branched peptides as targeting agents for tumor imaging and therapy
Brunetti, J.
Falciani, C.
Lelli, B.
Ravenni, N.
Pini, A.
Depau, L.
Lozzi, L.
Lapo, B.
Moretti, R.
Bracci, L.
EJC SUPPLEMENTS, 2010, 8 (07): : 33 - 34
[24] Investigation of the Molecular Design of PSMA-targeting Radioligands for Imaging of Prostate Cancer
Lundmark, F.
Olanders, G.
Rinne, S. S.
Abouzayed, A.
Orlova, A.
Rosenstrom, U.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S18 - S19
[25] Targeting of Breast Cancer: Molecular Imaging and Therapy
Padmanabhan, Parasuraman
Goggi, Julian
Bejot, Romain
Bhakoo, Kishore K.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2011, 12 (04) : 528 - 538
[26] Molecular Targeting Agents in Cancer Therapy: Science and Society
Shaikh, Asim Jamal
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (04) : 1705 - 1708
[27] Molecular targeting of the lymphovascular system for imaging and therapy
Schoder, Heiko
Glass, Edwin C.
Pecking, Alain P.
Harness, Jay K.
Wallace, Anne M.
Hirnle, Peter
Alberini, Jean L.
Vilain, Didier
Larson, Steven M.
Hoh, Carl K.
Vera, David R.
CANCER AND METASTASIS REVIEWS, 2006, 25 (02) : 185 - 201
[28] Molecular targeting of the lymphovascular system for imaging and therapy
Heiko Schöder
Edwin C. Glass
Alain P. Pecking
Jay K. Harness
Anne M. Wallace
Peter Hirnle
Jean L. Alberini
Didier Vilain
Steven M. Larson
Carl K. Hoh
David R. Vera
Cancer and Metastasis Reviews, 2006, 25 : 185 - 201
[29] Targeting NCA-95 and other granulocyte antigens and receptors with radiolabeled monoclonal antibodies (Mabs)
Meller, J.
Liersch, T.
Oezerden, M. M.
Sahlmann, C. -O.
Meller, B.
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 54 (06): : 582 - 598
[30] RADIOLABELED AGENTS FOR SPECT IMAGING OF BRAIN PERFUSION
WALOVITCH, RC
WILLIAMS, SJ
LAFRANCE, ND
NUCLEAR MEDICINE AND BIOLOGY, 1990, 17 (01): : 77 - 83

← 1 2 3 4 5 →